NDLI: Smoldering Multiple Myeloma

Content Provider	PubMed Central
Author	Gao, Minjie Yang, Guang Kong, Yuanyuan Wu, Xiaosong Shi, Jumei
Copyright Year	2015
Abstract	Smoldering multiple myeloma (SMM) is an asymptomatic precursor stage of multiple myeloma (MM) characterized by clonal bone marrow plasma cells (BMPC) ≥ 10% and/or M protein level ≥ 30 g/L in the absence of end organ damage. It represents an intermediate stage between monoclonal gammopathy of undetermined significance (MGUS) and symptomatic MM. The risk of progression to symptomatic MM is not uniform, and several parameters have been reported to predict the risk of progression. These include the level of M protein and the percentage of BMPC, the proportion of immunophenotypically aberrant plasma cells, and the presence of immunoparesis, free light-chain (FLC) ratio, peripheral blood plasma cells (PBPC), pattern of serum M protein evolution, abnormal magnetic resonance imaging (MRI), cytogenetic abnormalities, IgA isotype, and Bence Jones proteinuria. So far treatment is still not recommended for SMM, because several trials suggested that patients with SMM do not benefit from early treatment. However, the Mateos et al. trial showed a survival benefit after early treatment with lenalidomide plus dexamethasone in patients with high-risk SMM. This trial has prompted a reevaluation of early treatment in an asymptomatic patient population.
Related Links	http://dx.doi.org/10.1155/2015/623254
Starting Page	623254
File Format	PDF
ISSN	23146133
e-ISSN	23146141
Journal	BioMed Research International
Volume Number	2015
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2015-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Microbiology Medicine Biochemistry, Genetics and Molecular Biology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Smoldering multiple myeloma.

Smoldering multiple myeloma

How I treat smoldering multiple myeloma

Implications of Heterogeneity in Multiple Myeloma

Immunological Dysregulation in Multiple Myeloma Microenvironment

MMSET: Role and Therapeutic Opportunities in Multiple Myeloma

Deep Response in Multiple Myeloma: A Critical Review

Smoldering multiple myeloma requiring treatment: time for a new definition?

p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma

Smoldering Multiple Myeloma

Similar Documents

Smoldering multiple myeloma.

Smoldering multiple myeloma

How I treat smoldering multiple myeloma

Implications of Heterogeneity in Multiple Myeloma

Immunological Dysregulation in Multiple Myeloma Microenvironment

MMSET: Role and Therapeutic Opportunities in Multiple Myeloma

Deep Response in Multiple Myeloma: A Critical Review

Smoldering multiple myeloma requiring treatment: time for a new definition?

p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma

Smoldering Multiple Myeloma